Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Technische Universität Dresden

Clinical trials sponsored by Technische Universität Dresden, explained in plain language.

Trials to join now! 11 Not yet recruiting 4 Not yet finished but already full! 1 Completed 1

New hope for rare lung cancer: immunotherapy plus chemo shows promise

Disease control Ongoing

This study is for people with a rare and advanced type of lung cancer called large-cell neuroendocrine carcinoma. It tests whether adding the immunotherapy drug atezolizumab to standard chemotherapy can help patients live longer and control the cancer better. About 67 participant…

Phase: PHASE2 • Sponsor: Technische Universität Dresden • Aim: Disease control

Last updated May 14, 2026 12:02 UTC